| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/09/2006 | CA2156857C Human b-lymphoblastoid cell line secreting anti-ganglioside antibody |
| 05/09/2006 | CA2117913C Activation-state-specific phosphoprotein immunodetection |
| 05/09/2006 | CA1341505C Intravenously administered polyclonal immunoglobulin preparation containing igm and method of manufacture |
| 05/04/2006 | WO2006047639A2 Modulation of antibody specificity by tailoring the affinity to cognate antigens |
| 05/04/2006 | WO2006047367A2 Suppression of endogenous immunoglubolin expression in non-human transgenic animals |
| 05/04/2006 | WO2006047340A2 Methods for refolding of recombinant antibodies |
| 05/04/2006 | WO2006047298A2 Eph receptor tumor biomarkers |
| 05/04/2006 | WO2006047254A1 Assemblies of oligomeric amyloid beta protein and uses thereof |
| 05/04/2006 | WO2006047249A1 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 05/04/2006 | WO2006047204A1 Topiramate analogs |
| 05/04/2006 | WO2006047172A1 Tweak receptor |
| 05/04/2006 | WO2006046935A1 Methods of optimizing antibody variable region binding affinity |
| 05/04/2006 | WO2006046751A1 Anti-glypican 3 antibody having modified sugar chain |
| 05/04/2006 | WO2006046739A1 Remedy for inflammatory diseases |
| 05/04/2006 | WO2006046661A1 Interleukin-6 inhibitor |
| 05/04/2006 | WO2006046270A2 Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof |
| 05/04/2006 | WO2006046073A2 C1q related protein |
| 05/04/2006 | WO2006046042A2 Method of selecting polypeptides |
| 05/04/2006 | WO2006045849A1 T-cadherin antigen arrays and uses thereof |
| 05/04/2006 | WO2006045308A2 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 05/04/2006 | WO2006031653A3 Humanized anti-5t4 antibodies and anti-5t4 antibody / calicheamicin conjugates |
| 05/04/2006 | WO2006017456A3 Chymopapain isoenzymes, compositions, and uses thereof |
| 05/04/2006 | WO2006016276A3 Therapeutic and diagnostic methods and compositions targeting 4ig-b7-h3 and its counterpart nk cell receptor |
| 05/04/2006 | WO2006009809A3 Vegf inhibitors for the treatment of malignant pleural effusion |
| 05/04/2006 | WO2006002438A3 Human monoclonal antibodies to fc gamma receptor i (cd64) |
| 05/04/2006 | WO2006000719A3 COG47 PROTEIN AND S100β GENE POLYMORPHISM |
| 05/04/2006 | WO2005121174A3 Novel g-csf polypeptides, polynucleotides, modulators thereof, and methods of use |
| 05/04/2006 | WO2005117974A3 Cancer treatment method by inhibiting mage gene expression or function |
| 05/04/2006 | WO2005115461A3 Pharmaceutical composition for modulating the activity of triglyceride hydrolase |
| 05/04/2006 | WO2005090403A3 Method and apparatus for antibody purification |
| 05/04/2006 | WO2005089809A3 Calicheamicin conjugation by antibody deglycosylation |
| 05/04/2006 | WO2005086568A3 Anti-icam-1 human antibodies and uses thereof |
| 05/04/2006 | WO2005056600B1 Monoclonal antibodies that bind or neutralize dengue virus |
| 05/04/2006 | WO2005056585A3 Sars coronavirus s proteins and uses thereof |
| 05/04/2006 | WO2005021709A8 Cln101 antibodies |
| 05/04/2006 | WO2005016111A3 Antibodies directed to parathyroid hormone (PTH) and uses thereof |
| 05/04/2006 | WO2004040398A3 Use of a computer to design a molecule |
| 05/04/2006 | WO2004037972A3 Endogenous retrovirus up-regulated in prostate cancer |
| 05/04/2006 | WO2004030610A3 Compositions and methods for the intracellular delivery of antibodies |
| 05/04/2006 | US20060094864 Novel polypeptides and nucleic acid molecules encoding those polypeptides; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides fused to heterologous polypeptide sequences, and antibodies which bind to the polypeptides |
| 05/04/2006 | US20060094863 Nucleic acid capable of hybridizing, serving as a marker for diagnosing feline nephropathy |
| 05/04/2006 | US20060094862 Specificity exchangers that redirect antibodies to a pathogen |
| 05/04/2006 | US20060094101 Mk2 interacting proteins |
| 05/04/2006 | US20060094079 Protein for blocking platelet adhesion |
| 05/04/2006 | US20060094072 Peptide sequence tags and method of using same |
| 05/04/2006 | US20060094058 Peptide sequence tags and method of using same |
| 05/04/2006 | US20060094043 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 05/04/2006 | US20060094029 Catalyzes site specific recombination at a rox site |
| 05/04/2006 | US20060094017 Immunogens for hiv vaccine |
| 05/04/2006 | US20060094006 Immunotherapy regimens in hiv-infected patients |
| 05/04/2006 | US20060093616 Process for vaccinating eucaryotic hosts and for protecting against SARS-CoV infection |
| 05/04/2006 | US20060093612 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 05/04/2006 | US20060093610 Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS 06 of pseudomonas aeruginosa |
| 05/04/2006 | US20060093609 Vaccine against yersinia comprising one or two antibodies, one specific for yersinia pestis f1-antigen and the other one for yersinia pestis v-antigen |
| 05/04/2006 | US20060093604 Method of treatment and prophylaxis |
| 05/04/2006 | US20060093603 ErbB4 antagonists |
| 05/04/2006 | US20060093602 Inflammatory mediator antagonists |
| 05/04/2006 | US20060093601 Humanized anti-beta7 antagonists and uses therefor |
| 05/04/2006 | US20060093600 Antibodies to CD40 |
| 05/04/2006 | US20060093599 Anti-properdin antibodies, and methods for making and using same |
| 05/04/2006 | CA2820140A1 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 05/04/2006 | CA2586511A1 Immunoassays for lamotrigine |
| 05/04/2006 | CA2586506A1 Immunoassays for topiramate |
| 05/04/2006 | CA2586466A1 Topiramate analogs |
| 05/04/2006 | CA2585965A1 Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof |
| 05/04/2006 | CA2585717A1 Modulation of antibody specificity by tailoring the affinity to cognate antigens |
| 05/04/2006 | CA2585196A1 Anti-glypican 3 antibody having modified sugar chain |
| 05/04/2006 | CA2585188A1 Method of selecting polypeptides of interest using tus dna binding domains and dna binding sites |
| 05/04/2006 | CA2585011A1 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 05/04/2006 | CA2584814A1 Suppression of endogenous immunoglobulin expression in non-human transgenic animals |
| 05/04/2006 | CA2584804A1 Eph receptor tumor biomarkers |
| 05/04/2006 | CA2584489A1 Kaspp (lrrke) gene, its production and use for the detection and treatment of neurodegenerative disorders |
| 05/04/2006 | CA2584211A1 Methods for refolding of recombinant antibodies |
| 05/04/2006 | CA2584157A1 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 05/04/2006 | CA2583677A1 Tnf-like weak inducer of apoptosis (tweak) receptor binding domain |
| 05/03/2006 | EP1652925A1 IgM PRODUCTION BY TRANSFORMED CELLS AND METHODS FOR QUANTIFYING SAID IgM PRODUCTION |
| 05/03/2006 | EP1652924A2 Polypeptide, cDNA encoding the same and use thereof |
| 05/03/2006 | EP1652923A1 Gene overexpressed in cancer |
| 05/03/2006 | EP1652920A1 Methods of producing protein libraries and selection of proteins from them |
| 05/03/2006 | EP1652919A1 Improvements to ribosome display |
| 05/03/2006 | EP1652859A1 Immunoglobulin fractions |
| 05/03/2006 | EP1652856A1 Stress proteins-derived peptides and method of use thereof |
| 05/03/2006 | EP1652855A1 Polypeptides having brain disposition activity and utilization of the same |
| 05/03/2006 | EP1651955A2 Methods for detecting and analyzing n-glycolylneuraminic acid (neu5gc) in biological materials |
| 05/03/2006 | EP1651684A1 Etherified carbamate functional copolymers of isobutylene type monomers, and their use in curable compositions |
| 05/03/2006 | EP1651675A1 A variant cell surface molecule associated with cancer |
| 05/03/2006 | EP1651663A2 Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| 05/03/2006 | EP1651659A1 Methods for humanizing rabbit monoclonal antibodies |
| 05/03/2006 | EP1651269A2 Monoclonal antibodies against ricin toxin and methods of making and using thereof |
| 05/03/2006 | EP1651268A2 Design of disease specific agents for diagnostics and therapeutics based on the protein isoform of vegf, her-2, psa |
| 05/03/2006 | EP1651266A1 Administration of anti-cytokine f(ab')2 antibody fragments |
| 05/03/2006 | EP1651264A1 Subunit vaccine against respiratory syncytial virus infection |
| 05/03/2006 | EP1651260A1 Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof |
| 05/03/2006 | EP1651169A2 Combination therapies for multiple sclerosis |
| 05/03/2006 | EP1546205A4 Methods for regulating cancer |
| 05/03/2006 | EP1242060B1 Treatment of metastatic disease |
| 05/03/2006 | EP1212088B1 Use of anti rubeola antibodies for treatment of symptoms of central nervous system disorders |
| 05/03/2006 | EP1183390B8 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY |
| 05/03/2006 | EP1126863B1 Vascular endothelial growth factor-like protein from orf virus nz10 binds and activates mammalian vegf receptor-2 |
| 05/03/2006 | EP1105484B1 Antithrombin nucleotides and proteins from horn fly |